Thus far, only the 3xTg mouse model of AD, which expresses APP, PSEN1 and tau mutations, has shown increased resting phase activity alongside decreased active phase activity, reminiscent of the nocturnal awakenings and daytime sleepiness observed in AD patients [62]. Here, MAPT is linked to Alzheimer disease.